SCHEMBL9937023

SCHEMBL9937023

CC(=NO)c1cc(C(=O)NC(Cc2ccc(-c3ccccc3)cc2)CC(O)C(=O)O)[nH]n1

nearest known ligand 0.76

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MME P08473 20/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937016 1.00 MME (0.76) MME
SCHEMBL9930095 1.00 MME (0.76) MME
SCHEMBL9930097 1.00 MME (0.76) MME
SCHEMBL9929949 0.91 MME (0.85) MME
SCHEMBL18724641 0.91 MME (0.85) MME
SCHEMBL9938002 0.88 MME (0.80) MME
SCHEMBL9929678 0.88 MME (0.80) MME
SCHEMBL9929357 0.87 MME (1.00) MME
SCHEMBL9929359 0.87 MME (1.00) MME
SCHEMBL9930529 0.86 MME (0.78) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 WO disclosed